annual total liabilities:
$312.19M+$275.31M(+746.57%)Summary
- As of today (September 10, 2025), XENE annual total liabilities is $312.19 million, with the most recent change of +$275.31 million (+746.57%) on December 31, 2024.
- During the last 3 years, XENE annual total liabilities has risen by +$290.21 million (+1320.72%).
- XENE annual total liabilities is now at all-time high.
Performance
XENE Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$40.30M+$980.00K(+2.49%)Summary
- As of today (September 10, 2025), XENE quarterly total liabilities is $40.30 million, with the most recent change of +$980.00 thousand (+2.49%) on June 1, 2025.
- Over the past year, XENE quarterly total liabilities has increased by +$339.00 thousand (+0.85%).
- XENE quarterly total liabilities is now -87.09% below its all-time high of $312.19 million, reached on December 31, 2024.
Performance
XENE quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XENE Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +746.6% | +0.8% |
3 y3 years | +1320.7% | +86.7% |
5 y5 years | +460.3% | +88.5% |
XENE Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1320.7% | -87.1% | +86.7% |
5 y | 5-year | at high | +1650.8% | -87.1% | +180.0% |
alltime | all time | at high | >+9999.0% | -87.1% | +1282.6% |
XENE Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $40.30M(+2.5%) |
Mar 2025 | - | $39.32M(-87.4%) |
Dec 2024 | $312.19M(+746.6%) | $312.19M(+719.5%) |
Sep 2024 | - | $38.09M(-4.7%) |
Jun 2024 | - | $39.96M(+27.6%) |
Mar 2024 | - | $31.32M(-15.1%) |
Dec 2023 | $36.88M(+12.9%) | $36.88M(+6.9%) |
Sep 2023 | - | $34.50M(-10.3%) |
Jun 2023 | - | $38.44M(+16.8%) |
Mar 2023 | - | $32.92M(+0.8%) |
Dec 2022 | $32.65M(+48.6%) | $32.65M(+43.9%) |
Sep 2022 | - | $22.69M(+5.1%) |
Jun 2022 | - | $21.59M(+33.2%) |
Mar 2022 | - | $16.21M(-26.2%) |
Dec 2021 | $21.97M(+23.2%) | $21.97M(+42.6%) |
Sep 2021 | - | $15.41M(-13.1%) |
Jun 2021 | - | $17.73M(+23.2%) |
Mar 2021 | - | $14.39M(-19.3%) |
Dec 2020 | $17.83M(-68.0%) | $17.83M(+4.2%) |
Sep 2020 | - | $17.11M(-20.0%) |
Jun 2020 | - | $21.38M(-56.4%) |
Mar 2020 | - | $49.06M(-11.9%) |
Dec 2019 | $55.72M | $55.72M(+128.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $24.34M(+5.3%) |
Jun 2019 | - | $23.11M(+3.9%) |
Mar 2019 | - | $22.24M(+16.2%) |
Dec 2018 | $19.13M(+87.8%) | $19.13M(-0.9%) |
Sep 2018 | - | $19.30M(+30.3%) |
Jun 2018 | - | $14.81M(+59.9%) |
Mar 2018 | - | $9.26M(-9.1%) |
Dec 2017 | $10.19M(+184.1%) | $10.19M(+233.1%) |
Sep 2017 | - | $3.06M(-19.0%) |
Jun 2017 | - | $3.77M(+5.1%) |
Mar 2017 | - | $3.59M(+0.1%) |
Dec 2016 | $3.59M(+23.0%) | $3.59M(-11.7%) |
Sep 2016 | - | $4.06M(+34.1%) |
Jun 2016 | - | $3.03M(+1.4%) |
Mar 2016 | - | $2.99M(+2.5%) |
Dec 2015 | $2.92M(-80.1%) | $2.92M(-46.9%) |
Sep 2015 | - | $5.49M(-55.0%) |
Jun 2015 | - | $12.18M(+16.7%) |
Mar 2015 | - | $10.43M(-28.7%) |
Dec 2014 | $14.64M(-51.8%) | $14.64M(-23.6%) |
Sep 2014 | - | $19.16M(-18.8%) |
Jun 2014 | - | $23.61M(-22.3%) |
Dec 2013 | $30.37M(-40.1%) | $30.37M |
Dec 2012 | $50.68M | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual total liabilities?
- What is the all time high annual total liabilities for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual total liabilities year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly total liabilities year-on-year change?
What is Xenon Pharmaceuticals Inc. annual total liabilities?
The current annual total liabilities of XENE is $312.19M
What is the all time high annual total liabilities for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual total liabilities is $312.19M
What is Xenon Pharmaceuticals Inc. annual total liabilities year-on-year change?
Over the past year, XENE annual total liabilities has changed by +$275.31M (+746.57%)
What is Xenon Pharmaceuticals Inc. quarterly total liabilities?
The current quarterly total liabilities of XENE is $40.30M
What is the all time high quarterly total liabilities for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly total liabilities is $312.19M
What is Xenon Pharmaceuticals Inc. quarterly total liabilities year-on-year change?
Over the past year, XENE quarterly total liabilities has changed by +$339.00K (+0.85%)